tirzepatide cause kidney stones (Zepbound) showed improved function in obese patients with both chronic kidney disease and #heartfailure with preserved ejection fraction, highlighting its potential to address this high-risk patient population. Read more: https Tirzepatide Shows Kidney Benefits in

It binds to GLP-1 receptors in the body, which helps slow how quickly the stomach empties, supports a feeling of fullness after meals, and helps the pancreas release insulin at more appropriate times

Support Healthy Blood Sugar Levels*

The problem with this philosophy is that obesity is not a short-term condition

It also helps reduce the amount of insulin the body needs to produce

For patients experiencing significant gastrointestinal symptoms with semaglutide, temporary dose adjustment or slower titration may be considered in line with the SmPC guidance

Can weight loss help with conditions like high blood pressure or diabetes